William Demant Holding traded at 272.10 this Friday July 1st, increasing 5.80 or 2.18 percent since the previous trading session. Looking back, over the last four weeks, William Demant Holding gained 9.93 percent. Over the last 12 months, its price fell by 25.23 percent. Looking ahead, we forecast William Demant Holding to be priced at 277.85 by the end of this quarter and at 247.44 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
272.10
Daily Change
2.18%
Yearly
-25.23%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
EDAP TMS 6.60 -0.20 -2.94% -4.35%
Essilor 143.85 0.95 0.66% -5.64%
Fresenius Medical Care 47.58 -0.05 -0.11% -31.08%
Fresenius 29.14 0.24 0.83% -34.71%
Genmab 2,361.00 64.00 2.79% -9.30%
Getinge 241.00 4.60 1.95% -25.16%
GN Store Nord 259.00 10.30 4.14% -53.85%
Lonza Group 519.20 10.20 2.00% -20.78%
Philips 20.18 -0.38 -1.82% -50.44%
Pandora 451.50 5.00 1.12% -47.45%
Smith & Nephew PLC 1,150.50 3.00 0.26% -27.71%
Smith Nephew 27.97 0.05 0.18% -36.68%
Trinity Biotech 1.32 0.10 7.76% -53.02%
William Demant Holding 272.10 5.80 2.18% -25.23%

Indexes Price Day Year
Copenhagen 1652 15.13 0.92% -1.29%

William Demant Holding
Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.